NextPlat Corp. (NASDAQ:NXPL – Get Free Report) was the recipient of a significant increase in short interest in the month of February. As of February 27th, there was short interest totaling 518,283 shares, an increase of 227.4% from the February 12th total of 158,290 shares. Based on an average daily volume of 1,458,650 shares, the days-to-cover ratio is presently 0.4 days. Approximately 3.5% of the shares of the company are sold short. Approximately 3.5% of the shares of the company are sold short. Based on an average daily volume of 1,458,650 shares, the days-to-cover ratio is presently 0.4 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of NextPlat in a research note on Monday, December 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.
Read Our Latest Stock Report on NXPL
NextPlat Trading Down 4.8%
Institutional Investors Weigh In On NextPlat
An institutional investor recently bought a new position in NextPlat stock. Simplicity Wealth LLC purchased a new position in NextPlat Corp. (NASDAQ:NXPL – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 600,000 shares of the company’s stock, valued at approximately $497,000. Simplicity Wealth LLC owned 2.31% of NextPlat at the end of the most recent quarter. Hedge funds and other institutional investors own 1.30% of the company’s stock.
About NextPlat
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Recommended Stories
- Five stocks we like better than NextPlat
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
